US FDA’s RWE Efforts Gain ‘Focal Point’ With New CDER Center

The Center for Real-World Evidence Innovation will promote consistency across the FDA drug center’s many initiatives while addressing regulatory and scientific barriers to real-world evidence in regulatory decisions.

The CDER Center for Real-World Evidence Innovation is intended to focus and clarify the center's many RWE initiatives. (Shutterstock)

More from Real-World Evidence

More from R&D